AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
πΏπΌ
METFORMIN HYDROCHLORIDE; VILDAGLIPTIN in Zimbabwe
12 products registered with MCAZ β 12 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| VILDAGLIN-M 50/850 TABLET, COATED; ORAL | 2026/17.7/7424 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | active | 6 May 2031 |
| VIDAGLIN-M 50/1000 TABLET, COATED; ORAL | 2026/17.7/7312 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | active | 17 Feb 2031 |
| VIDAGLIN-M 50/500 TABLET, COATED; ORAL | 2026/17.7/7311 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | active | 17 Feb 2031 |
| ALVUS-CO 50/850 TABLET; ORAL | 2025/17.7/7000 | INNOVATA PHARMACEUTICALS | active | 8 Jul 2030 |
| ALVUS-CO 50/1000 TABLET; ORAL | 2025/17.7/7001 | INNOVATA PHARMACEUTICALS | active | 8 Jul 2030 |
| SKY PHARM VILDAGLIPTIN 50MG/METFORMIN 1000MG TABLET, COATED; ORAL | 2025/17.7/6967 | ADVENTURA INVESTMENTS LTD | active | 22 May 2030 |
| GALVUS MET TABLET, COATED; ORAL | 2015/17.7/5030 | NOVARTIS PHARMA SERVICES AG | active | 31 Dec 2027 |
| INCREMET-V 50/1000 TABLET, COATED; ORAL | 2025/17.7/7144 | COSPHARM INVESTMENTS PVT LTD | active | 31 Dec 2027 |
| GALVUS MET TABLET, COATED; ORAL | 2015/17.7/5028 | NOVARTIS PHARMA SERVICES AG | active | 31 Dec 2027 |
| GALVUS MET TABLET, COATED; ORAL | 2015/17.7/5029 | NOVARTIS PHARMA SERVICES AG | active | 31 Dec 2027 |
| INCREMET-V 50/850 TABLET, COATED; ORAL | 2025/17.7/7143 | COSPHARM INVESTMENTS PVT LTD | active | 31 Dec 2027 |
| VILIP M 1000 TABLET, COATED; ORAL | 2026/17.7/7422 | PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD | active | β |
METFORMIN HYDROCHLORIDE; VILDAGLIPTIN β MCAZ Registration Details
MCAZ (Zimbabwe) has 12 registered products containing METFORMIN HYDROCHLORIDE; VILDAGLIPTIN, of which 12 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track METFORMIN HYDROCHLORIDE; VILDAGLIPTIN registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.